Kraig Biocraft Laboratories, Inc. (KBLB) is the world leader in the development of recombinant
technologies
and recombinant fibers for the global textile and technical textile markets.
On April 12, 2011 we
announced
a landmark deal with
biotechnology
giant Sigma-Aldrich that we believe will pave the way for the future of our Company.
On November 3, 2011 we announced a second landmark with the signing of a commercial Spider SIlk licensing agreement with the University of Notre Dame whereby the University became a Kraig shareholder.
On November 14, 2011 we
announced yet another
breakthrough: The success
of our micro-injections of Sigma-Aldrich's zinc finger technology, and the creation of seven new strains of ZF transgenics.
On January 5, 2012 we announced that the
National Academy of Sciences published the peer-reviewed scientific article describing our spider silk breakthrough in the
prestigious
journal Proceedings of the National Academy of Sciences. Congratulations to our scientific team!
We are an
innovative
and aggressive biotechnology company focused on the development
and commercialization
of commercially significant high performance polymers and technical fiber. Based on proprietary genetic engineering technology, Kraig has
successfully
developed and produced next generation polymers and protein-based fibers including recombinant spider silk. Our work has recently
succeeded
in creating and developing new fibers
that have never been seen before with
extraordinary
properties of
strength,
flexibility
and beauty. Our
research
arm remains focused on the continued development of new recombinant spider silks and other high
strength
polymers that we believe have the potential for significant industrial and consumer applications.
Applications of High Performance Fibers
High performance technical fibers are currently used in a
wide variety of military, industrial, and consumer applications
requiring superior strength, toughness and flexibility.
A Note on the
Domesticated Silkworm
Interview with Company CEO Kim K Thompson: Transcript |
